Russell Investments Group
NUVB icon

Russell Investments Group’s Nuvation Bio NUVB Stock Holding History

Russell Investments Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Buy
484,428
+218,728
+82% +$1.07M ﹤0.01% 1899
2026
Q1 		$1.14M Buy
265,700
+241,244
+986% +$1.34M ﹤0.01% 2150
2025
Q4 		$219K Buy
24,456
+3,681
+18% +$22.8K ﹤0.01% 2818
2025
Q3 		$76.9K Buy
20,775
+20,671
+19,876% +$56.3K ﹤0.01% 3118
2025
Q2 		$203 Sell
104
-15,791
-99% -$32.9K ﹤0.01% 3789
2025
Q1 		$28K Hold
15,895
– – ﹤0.01% 3042
2024
Q4 		$42.3K Buy
15,895
+15,791
+15,184% +$40.7K ﹤0.01% 2856
2024
Q3 		$238 Sell
104
-89,960
-100% -$274K ﹤0.01% 3622
2024
Q2 		$263K Buy
90,064
+56,485
+168% +$172K ﹤0.01% 2405
2024
Q1 		$122K Sell
33,579
-4,500
-12% -$8.64K ﹤0.01% 2539
2023
Q4 		$57.5K Buy
38,079
+5,526
+17% +$7.11K ﹤0.01% 2625
2023
Q3 		$43.6K Buy
32,553
+6,421
+25% +$10.7K ﹤0.01% 2772
2023
Q2 		$47K Hold
26,132
– – ﹤0.01% 2730
2023
Q1 		$43.4K Buy
+26,132
New +$53K ﹤0.01% 2730

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Russell Investments Group's NUVB Position: Q2 2026 in Review

Russell Investments Group increased its Nuvation Bio (NUVB) stake by 82% in Q2 2026, buying an estimated $1.07M and bringing the position to 484,428 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Russell Investments Group first reported a position in NUVB in Q1 2023 and has held it in 14 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Russell Investments Group held 484,428 shares of Nuvation Bio worth $2.75M as of Q2 2026.
  • Russell Investments Group bought 218,728 Nuvation Bio shares in Q2 2026, an estimated $1.07M.
  • Nuvation Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1899 holding.
  • Russell Investments Group first reported a position in Nuvation Bio in Q1 2023 and has held it in 14 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.